Am J Epidemiol

1. LAHOOD A, Robins J, Stagg HR, Sauer S, et al
   Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.
   Am J Epidemiol. 2026 Feb 2:kwag024. doi: 10.1093.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

2. LAMONT EA, Kordus SL, Howe MD, Jia Z, et al
   Essential role of MHC II in the antitubercular efficacy of pyrazinamide.
   Antimicrob Agents Chemother. 2026;70:e0126425.
   

   >> Share

   
   

   
   Clin Infect Dis

3. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
   Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
   Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
   

   >> Share

   
   
4. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
   Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
   Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
   

   >> Share

   
   
5. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
   Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
   Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Tuberc Lung Dis

6. SANA H, Saunders MJ, McQuaid CF, Dauphinais MR, et al
   Nutritional interventions for TB: a critical component of integrated TB care amid funding challenges.
   Int J Tuberc Lung Dis. 2026;30:45-47.
   

   >> Share

   
   
7. WARDANI NHK, Tjia KD
   Spatiotemporal and risk factor analysis of drug-sensitive and drug-resistant TB in West Java, 2020-2022.
   Int J Tuberc Lung Dis. 2026;30:56-62.
   

   >> Share

   
   
8. KIWANUKA N, Quach HT, Kakaire R, Zalwango S, et al
   Incidence of Mycobacterium tuberculosis infection in an African city with endemic TB.
   Int J Tuberc Lung Dis. 2026;30:70-76.
   

   >> Share

   
   
9. OU WF, Chu CH, Sheu CC, Chang CL, et al
   Lower FEV(1) and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasis.
   Int J Tuberc Lung Dis. 2026;30:63-69.
   

   >> Share

   
   
10. KHAW CR, Malhotra AM, Tehranchi S, Rahman A, et al
    Extra-pulmonary TB: a comparison between migrants and populations born in a low-incidence country.
    Int J Tuberc Lung Dis. 2026;30:77-83.
    

    >> Share

    
    

    
    J Infect Dis

11. RYCKMAN TS, Shrestha S, Fojo AT, Kasaie P, et al
    Modeling the impact of case finding for tuberculosis: The role of infection dynamics.
    J Infect Dis. 2026 Jan 30:jiag050. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS Med

12. SCHWALB A, Dodd PJ, Rickman HM, Ugarte-Gil CA, et al
    Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.
    PLoS Med. 2026;23:e1004920.
    

    >> Share

    
    

    
    PLoS One

13. GEBRIE E, Baynes HW, Mengistie BA, Kassie T, et al
    Sex hormone profiles and associated factors among adult tuberculosis patients at Gondar town, northwest Ethiopia: A comparative cross-sectional study.
    PLoS One. 2026;21:e0340631.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share